Contract Services Clinical Research
Chime Biologics and Hope Medicine Accelerate First-in-Class Antibody Drug HMI-115 for Endometriosis and Androgenic Alopecia
Chime Biologics to support the late-stage clinical study and to provide global commercial manufacturing services for Hope Medicine...
October 27, 2023 | News
Metabolon and Genomics England Partner to Advance Rare Disease Diagnosis
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...
October 26, 2023 | News
PharmaKure submits for Alzheimer's Disease Combined Drug Clinical Trial
PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease and other neurodegenerative diseases...
October 25, 2023 | News
XINGIMAGING and MITRO BIOTECH Merge for Global CRO Operations
As a combined company, Mitro will expand its capabilities to provide full CRO services, including clinical and clinical imaging management, in China&n...
October 24, 2023 | News
Regeneron and Sanofi Share Latest on Dupixent® sBLA for Chronic Urticaria
CSU is an inflammatory skin condition, which causes sudden and debilitating hives and swelling on the skin. The CRL states that additional efficacy data ar...
October 23, 2023 | News
Aragen Commissions state-of-the-art Formulations Manufacturing Facility in India
This state-of-the-art facility, set up at an investment of USD 3Mn, is located at the Mallapur Campus in Hyderabad and spans over 12,000 square feet area. ...
October 20, 2023 | News
CANbridge Reaches Full Enrollment in Phase 2 Trial for Gaucher Disease in China
Phase 2 is a randomized, double-blind, dose comparison study to evaluate the efficacy, safety and pharmacokinetics of CAN103 in newly treated GD patients, ...
October 17, 2023 | News
WuXi Biologics Introduces WuXiUI™: Enhancing Bioprocessing for Efficiency and Quality in Commercial Manufacturing
WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...
October 17, 2023 | News
Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment
The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...
October 16, 2023 | News
Metabolon Introduces Liver and Kidney Panels for Disease Research
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...
October 13, 2023 | News
Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer Integrated mRNA Services: A Blueprint for Advancing Biopharma
In this interview, we explore the significance of Merck's €1 billion investment in advancing mRNA technologies, the impact of their acqu...
October 11, 2023 | News
GE HealthCare Expands Human Subject Research with Stanford Medicine Using Photon Counting CTi Technology
Unique from current CT technology, GE HealthCare’s proprietary photon counting CT design is engineered to leverage Deep Silicon detectors with the ...
October 10, 2023 | News
Innovent Initiates Phase 3 Study of Efdamrofusp Alfa for Age-related Macular Degeneration
nnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality med...
October 09, 2023 | News
GE Healthcare and University Hospitals Announce 10-Year Collaboration to Enhance Imaging and Digital Solutions
Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE HealthCare and University Hospitals (UH) today announ...
October 06, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
